COSCIENS Biopharma (CSCI)
NASDAQ:CSCI
Holding CSCI?
Track your performance easily

COSCIENS Biopharma (CSCI) Technical Analysis

906 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
COSCIENS Biopharma’s (CSCI) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting COSCIENS Biopharma is a Sell.
COSCIENS Biopharma’s (CSCI) 20-Day exponential moving average is 5.91, while COSCIENS Biopharma’s (CSCI) share price is $6.18, making it a Buy.
COSCIENS Biopharma’s (CSCI) 50-Day exponential moving average is 6.08, while COSCIENS Biopharma’s (CSCI) share price is $6.18, making it a Buy.

COSCIENS Biopharma (CSCI) Pivot Points

Aug 25, 2024, 03:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.64
5.73
5.88
5.97
6.12
6.21
6.36
Fibonacci
5.73
5.82
5.87
5.97
6.06
6.11
6.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

COSCIENS Biopharma (CSCI) Moving Averages

Aug 25, 2024, 03:22 AM
Period
Simple
Exponential
MA5
5.94Buy
6.02Buy
MA10
6.06Buy
5.97Buy
MA20
5.87Buy
5.91Buy
MA50
5.63Buy
6.08Buy
MA100
6.88Sell
6.57Sell
MA200
7.29Sell
7.10Sell
COSCIENS Biopharma’s (CSCI) 10-Day exponential moving average is 5.97, while COSCIENS Biopharma’s (CSCI) share price is $6.18, making it a Buy.
COSCIENS Biopharma’s (CSCI) 100-Day exponential moving average is 6.57, while COSCIENS Biopharma’s (CSCI) share price is $6.18, making it a Sell.
COSCIENS Biopharma’s (CSCI) stock price is $6.18 and COSCIENS Biopharma’s (CSCI) 50-day simple moving average is 5.63, creating a Buy signal.
COSCIENS Biopharma’s (CSCI) stock price is $6.18 and COSCIENS Biopharma’s (CSCI) 100-day simple moving average is 6.88, creating a Sell signal.
COSCIENS Biopharma’s (CSCI) stock price is $6.18 and COSCIENS Biopharma’s (CSCI) 200-day simple moving average is 7.29, creating a Sell signal.

COSCIENS Biopharma (CSCI) Technical Indicators

Aug 25, 2024, 03:22 AM
Name
Value
Implied Action
RSI (14)
55.19
Neutral
STOCH (9,6)
45.79
Neutral
STOCHRSI (14)
54.40
Neutral
MACD (12,26)
0.05
Sell
ADX (14)
11.23
Buy
Williams %R
-40.15
Buy
CCI (14)
55.18
Neutral
ATR (14)
0.46
-
Ultimate Oscillator
33.84
Neutral
ROC
16.60
Buy
COSCIENS Biopharma’s (CSCI) Relative Strength Index (RSI) is 55.19, creating a Neutral signal.
COSCIENS Biopharma’s (CSCI) Trend Strength Indicator (ADX) is 11.23, creating a Buy signal.
COSCIENS Biopharma’s (CSCI) Commodity Channel Index (CCI) is 55.18, creating a Neutral signal.
COSCIENS Biopharma’s (CSCI) Price Rate of Change (ROC) is 16.60, creating a Buy signal.

FAQ

Is CSCI a Buy, Hold, or Sell?
Based on CSCI’s technical indicators, CSCI is a Buy.
    What is CSCI’s RSI (14)?
    CSCI’s RSI (14) is 55.19, which suggests CSCI is a Neutral.
      What is CSCI’s MACD?
      CSCI’s MACD is 0.05, which suggests CSCI is a Sell.
        What is CSCI’s 5-day moving average?
        CSCI’s 5-day moving average is 5.94, which suggests CSCI is a Buy.
          What is CSCI’s 20-day moving average?
          CSCI 20-day moving average is 5.87, which suggests CSCI is a Buy.
            What is CSCI’s 50-day moving average?
            CSCI’s 50-day moving average is 5.63, which suggests CSCI is a Buy.
              What is CSCI’s 200-day moving average?
              CSCI’s 200-day moving average is 7.29, which suggests CSCI is a Sell.
                What is CSCI’s Williams % R (14)?
                CSCI’s Williams % R (14) is -40.15, which suggests CSCI is a Buy.
                  What is CSCI’s CCI (14)?
                  CSCI’s CCI (14) is 55.18, which suggests CSCI is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis